Pathologic Complete Response and Individual Patient Prognosis After Neoadjuvant Chemotherapy Plus Anti–Human Epidermal Growth Factor Receptor 2 Therapy of Human Epidermal Growth Factor Receptor ...
Please provide your email address to receive an email when new articles are posted on . Removal of lymph nodes in the retroperitoneum for early metastatic testicular seminoma resulted in a 2-year RFS ...
On the basis of National Comprehensive Cancer Network guidelines, clinical stage (CS) II seminoma is treated with radiotherapy or chemotherapy. Primary retroperitoneal lymph node dissection (RPLND) ...
Luca Antonelli, MD; Davide Ardizzone, MD; Isamu Tachibana, MD; Nabil Adra, MD; Clint Cary, MD; Lee Hugar, MD; Wade J. Sexton, MD; Aditya Bagrodia, MD; Michal Mego, MD ...
Please provide your email address to receive an email when new articles are posted on . SAN FRANCISCO — Retroperitoneal lymph node dissection conferred favorable survival rates among men with ...
SAN FRANCISCO — Retroperitoneal lymph node dissection (RPLND) could potentially be a first-line option for men with stage II A/B testicular seminoma in order to reduce long-term toxicity and secondary ...
Men with nonseminomatous germ cell tumors (NSGCTs) who are at high risk of metastasis can benefit from retroperitoneal lymph node dissection (RPLND) as primary treatment, a recent study from Harvard ...
With the goals of informing surgical management, improving long-term outcomes and lowering death rates of patients with testicular cancer, a study has found that the conventional, versatile open ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback